logo

Novocure (NVCR)



Trade NVCR now with
  Date
  Headline
7/22/2020 7:35:17 AM Novocure Says First Patient Enrolled In EF-33 Phase 2 Pilot Trial
7/8/2020 7:34:20 AM Novocure Says About 100 Physicians From More Than 50 Cancer Treatment Centers In U.S. Certified To Prescribe Optune Lua
7/7/2020 7:37:38 AM Novocure Enrolls Last Patient In HEPANOVA Trial In Advanced Liver Cancer
3/20/2020 9:22:47 AM Novocure : German Federal Joint Committee Updates Medical Care Directive To Include Tumor Treating Fields
1/9/2020 7:34:16 AM Zai Lab, Novocure : First Patient Enrolled In Phase 2 Pilot Trial Of Tumor Treating Fields Together With Chemotherapy
8/16/2019 7:55:08 AM Can NovoCure Hit $100?
7/26/2019 8:36:26 AM Wedbush Is Cutting NovoCure (NVCR) FY20 Rev. Estimate To 484.6 M From 1601 M
7/26/2019 8:36:01 AM Wedbush Is Lowering NovoCure (NVCR) Q4 20 Rev. Estimate To 132.8 M From 1163 M
7/26/2019 8:35:49 AM Wedbush Is Lowering NovoCure (NVCR) Q3 20 Rev. Estimate To 124.8 M From 866.4 M
7/26/2019 8:35:24 AM Wedbush Is Cutting NovoCure (NVCR) Q2 20 Rev. Estimate To 118.8 M From 609.0 M
7/26/2019 8:35:11 AM Wedbush Is Lowering NovoCure (NVCR) Q1 20 Rev. Estimate To 108.2 M From 492.1 M
7/26/2019 8:34:51 AM Wedbush Is Increasing NovoCure (NVCR) FY19 Rev. Estimate To 351.1 M From 348.3 M
7/26/2019 8:34:40 AM Wedbush Is Cutting NovoCure (NVCR) Q4 19 Rev. Estimate To 99.9 M From 101.0 M
7/26/2019 8:34:29 AM Wedbush Is Lowering NovoCure (NVCR) Q3 19 Rev. Estimate To 91.2 M From 93.4 M
7/26/2019 8:34:04 AM Wedbush Is Cutting NovoCure (NVCR) FY20 Estimate To 0.63 From 8.09
7/26/2019 8:33:53 AM Wedbush Is Lowering NovoCure (NVCR) Q4 20 Estimate To 0.20 From 4.91
7/26/2019 8:33:41 AM Wedbush Is Lowering NovoCure (NVCR) Q3 20 Estimate To 0.17 From 2.95
7/26/2019 8:33:28 AM Wedbush Is Lowering NovoCure (NVCR) Q2 20 Estimate To 0.15 From 1.21
7/26/2019 8:33:16 AM Wedbush Is Cutting NovoCure (NVCR) Q1 20 Estimate To 0.10 From 0.63
7/26/2019 8:18:35 AM Wedbush Is Raising NovoCure (NVCR) FY19 Estimate To -0.09 From -0.19